Navigation Links
The In View series hosted by Larry King Announces plans for a series on Autoimmune Diseases
Date:2/8/2013

Boca Raton, FL (PRWEB) February 08, 2013

The producers of the In View TV series, an educational TV series hosted by Larry King, have announced plans to focus on autoimmune diseases and the push to cure them in an upcoming series. These diseases, which have no cure and often have nebulous causes, afflict tens of millions of Americans, affecting their health and quality of life. Diseases that come under this classification include type-I diabetes, multiple sclerosis and rheumatoid arthritis. The In View Larry King show, which runs on cable outlets across the country, will inform TV audiences about some of the many autoimmune diseases, in which the body’s immune system attacks and destroys healthy tissues and cells, as well as efforts to cure these diseases and develop better treatments for them. The Larry King TV show will spotlight researchers as well as companies across the country working to develop cures and treatments.

In November, researchers at the National Institute of Biomedical Imaging and Bioengineering announced a possible breakthrough in the treatment of autoimmune diseases. The institute’s approach involved re-educating the body’s T-cells to not attack healthy tissue. This series of the In View with Larry King show (http://www.inviewseries.com) will look at advances such as this and more, giving rare attention to diseases and patients that often get overlooked. The In View TV series (855-446-8439) will showcase organizations and companies that have made progress in the fight against various autoimmune disorders and diseases.

The Larry King In View show (561-544-7965) offers enlightening ep
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
2. DuPont Pioneer Launches Next Generation T Series Soybeans
3. Management Matters Series Starts with “Lab Budgeting 101”
4. QSI Announces RS Series of Deep Cooled CCD Cameras
5. Cieri Media Announces New Science Series 'Bright Ideas' Focusing on Latest Inventions
6. Rudy Mazzocchi Prepares to Release the Second Thriller in The EQUITY Series Trilogy, entitled EQUITY of FEAR
7. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
8. BioTechniques Announces the Publication of 'Transfection' – The First Issue of a New, Digital-Only Spotlight Series
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
11. Advanced Cell Diagnostics Completes $12 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Die SARAH-Studie ... Assistance Publique - Hôpitaux de ... französische, gemeinschaftliche, randomisierte Kontrollstudie für die mehr ... werden Patienten mit fortgeschrittenem hepatozellulärem Karzinom (HCC), ... behandelt wurden. Die Ergebnisse werden für Ende ...
(Date:3/5/2015)... Buffalo, New York (PRWEB) March 05, 2015 ... want veterans to be able to get an Advanced ... Time, money, stress, blaming and guessing are all risk ... with assuming the woman is the source of the ... and female. LifeCell Dx has the simplest, least ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 North ... Pierre Noel, M.D., Professor of Medicine, Mayo Clinic ... Company’s Board of Directors. , Entegrion’s ... extremely fortunate to have Dr. Noel, a distinguished ... healthcare organization, join Entegrion’s Board. His expertise in ...
(Date:3/5/2015)... , March 5, 2015  In response to ... Miami, FL on February 12, ... both of strong financial health and their SUDOSCAN® devices ... research has indicated. Furthermore, Impeto prefers to have the courts ... There are more than 40 articles written by Key ...
Breaking Biology Technology:Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 2Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 3Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 4Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 5Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 6LifeCell Dx Offers New Option to Veterans with Infertility 2LifeCell Dx Offers New Option to Veterans with Infertility 3Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2
... Sept. 28 Decision Resources, one of the world,s ... issues finds that, owing to increasing generic availability of ... $26 billion in 2009 to $23 billion in 2019 ... Kingdom and Japan. The Pharmacor 2010 findings ...
... Clarisonic announced today the expansion of its commitment ... Look Good…Feel Better ®, ... breast and other cancers manage their treatment and recovery ... free workshops, volunteer beauty professionals teach patients easy and ...
... Researchers at Rensselaer Polytechnic Institute are leading a ... bottleneck slowing the proliferation of large-scale wind and solar ... from the U.S. National Science Foundation, the four-year study ... a new approach to energy storage. Rather than batteries, ...
Cached Biology Technology:Due to Generic Erosion, the Hypertension Drug Market Will Decline by $3 Billion from 2009 to 2019 2Clarisonic Empowers Cancer Patients to Put Their Best Face Forward 2Clarisonic Empowers Cancer Patients to Put Their Best Face Forward 3Clarisonic Empowers Cancer Patients to Put Their Best Face Forward 4Clarisonic Empowers Cancer Patients to Put Their Best Face Forward 5Rethinking renewables: A new approach to energy storage for wind and solar 2
(Date:2/13/2015)... ACT Genomics Co., Ltd., a cancer ... cancer genomic information into precision diagnosis and personalized ... US$ 8 million in the its first private funding ... Taiwan , ACT Genomics has developed comprehensive ... to implement next generation sequencing (NGS) and multiplex ...
(Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
... University will be floating high above the Gulf of ... experimental DNA analysis instrument developed at Tech that could ... professor of mechanical engineering, and Collin Tranter, a graduate ... the instrument could be used to monitor the health ...
... lab for a test drive with the people who ... develop possible future scenarios. James Millington, a former ... Integration and Sustainability (CSIS) and now a Leverhulme Early ... the relatively new use of agent-based land-use modeling with ...
... cat owners are not sure how to react when their ... similar conditions is particularly difficult because the symptoms are so ... described as "looking into space" which is generally considered ... time anyway. But when it is followed by twitching ...
Cached Biology News:Louisiana Tech University researchers, NASA partner to conduct zero-gravity experiments 2Engaging land-use stakeholders is model behavior 2Seizing the opportunity: treating epilepsy in cats 2
... an ideal small concentrator for the molecular ... removing water and organic solvents from a ... vials and round bottom flasks. Making it ... lab. ,The built-in special runs for working ...
... is a compact, versatile & modular instrument which ... including: Intracellular, Extracellular, Transducer & Multi-channel Isolated ... Case & Power Supply unit (NL900D) forms the ... not only powered by this unit, but wiring ...
... is a four-channel general purpose laboratory amplifier. It ... sources which may have a large common-mode level ... a high gain/low noise amplifier, an input coupling ... offset control. A control knob sets the amplifier ...
sPLA2-XII Human, Rabbit Polyconal Antibody Anti-Human sPLA2-XII Antibody was raised in rabbits against Human sPLA2-XII His-Tagged Fusion Protein Antigen: The recombinant human protein sPLA-XII...
Biology Products: